| First Author | Gather R | Year | 2020 |
| Journal | Eur J Immunol | Volume | 50 |
| Issue | 11 | Pages | 1770-1782 |
| PubMed ID | 32419134 | Mgi Jnum | J:298127 |
| Mgi Id | MGI:6473053 | Doi | 10.1002/eji.201948123 |
| Citation | Gather R, et al. (2020) Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis. Eur J Immunol 50(11):1770-1782 |
| abstractText | Familial hemophagocytic lymphohistiocytosis (FHL) is a hyperinflammatory syndrome affecting patients with genetic cytotoxicity defects. Perforin-deficient (PKO) mice recapitulate the full clinical picture of FHL after infection with lymphocytic choriomeningitis virus (LCMV). Hyperactivated CD8(+) T cells and IFN-gamma have been identified as the key drivers of FHL and represent targets for therapeutic interventions. However, the response of patients is variable. This could be due to trigger-dependent differences in pathogenesis, which is difficult to address in FHL patients, since the trigger frequently escapes detection. We established an alternative FHL model using intravenous infection of PKO mice with murine CMV (MCMV)Smith . PKO mice developed acute FHL after both infections and fulfilled HLH diagnostic criteria accompanied by excessive IFN-gamma production by disease-inducing T cells, that enrich in the BM. However, direct comparison of the two infection models disclosed trigger-dependence of FHL progression and revealed a higher contribution of CD4 T cells and NK cells to IFN-gamma production after MCMV infection. Importantly, therapeutic intervention by IFN-gamma neutralization or CD8(+) T-cell depletion had less benefit in MCMV-triggered FHL compared to LCMV-triggered FHL, likely due to MCMV-induced cytopathology. Thus, the context of the specific triggering viral infection can impact the success of targeted immunotherapeutic HLH control. |
